logo
episode-header-image
Aug 2025
11m 48s

CT Colonography vs Multitarget Stool DNA

THE RADIOLOGICAL SOCIETY OF NORTH AMERICA
About this episode

Dr. Refky Nicola speaks with Dr. Perry Pickhardt about his study comparing CT colonography and multi-targeted stool DNA testing for colorectal cancer screening. They explore differences in sensitivity, specificity, cost-effectiveness, and strategies to optimize detection while minimizing invasiveness.

CT Colonography versus Multitarget Stool DNA Test forColorectal Cancer Screening: A Cost-Effectiveness Analysis. Pickhardt et al. Radiology 2025; 315(3):e243775.

Up next
Sep 22
Bridging the Gap in Breast Imaging
Dr. Reni Butler speaks with Dr. Bryan Haslam, Dr. Greg Sorensen, Dr. Matt McCabe, and Dr. Christoph Lee about their large real-world study evaluating an AI driven workflow for screening mammography across 109 U.S. facilities. Together, they explore how AI helped general radiologi ... Show More
26m 30s
Sep 15
Standardized Knee Meniscus MRI Reporting -Sponsored by GE HealthCare
Host Dr. Linda Chu sits down with Dr. Jie Nguyen, Dr. Todd Lawrence, and Dr. Kirk Davis to discuss an interdisciplinary consensus on standardized knee meniscus MRI reporting and the terminology that improves communication between radiologists and orthopedic surgeons. Together, th ... Show More
41m 45s
Sep 8
Prostate Cancer EMPIRE 2 Findings
Dr. Ashwin Parihar speaks with Dr. Olayinka A. Abiodun-Ojo and Dr. David M. Schuster about findings from the EMPIRE 2 trial, exploring how fluciclovine PET and PSMA PET influence salvage radiotherapy planning for men with recurrent prostate cancer after prostatectomy. The discuss ... Show More
22m 45s
Recommended Episodes
May 2024
S2 Episode 1: Tumor Trash or Treasure? Liquid Biopsy for Colorectal Cancer
Are you using liquid biopsies in your practice? Join Drs Benjamin Schlechter and Pashtoon Kasi as they review the latest clinical applications of ctDNA and liquid biopsies in colorectal cancer. Relevant disclosures can be found with the episode show notes on Medscape https://www. ... Show More
27m 24s
Jan 2014
Effect of 3 to 5 Years of Scheduled CEA and CT Follow-up to Detect Recurrence of Colorectal Cancer: The FACS Randomized Clinical Trial
Interview with John N. Primrose, MD, FRCS, author of Effect of 3 to 5 Years of Scheduled CEA and CT Follow-up to Detect Recurrence of Colorectal Cancer: The FACS Randomized Clinical Trial 
5m 46s
Mar 2025
What Everyone Gets Wrong about Colonoscopies
Colonoscopy gets a bad rap, but how much of what you’ve heard is actually true? In recognition of Colorectal Cancer Awareness Month, we’re tackling the biggest myths that keep people from getting this potentially lifesaving screening. John Nathanson, a gastroenterologist at Colum ... Show More
10m 34s
Feb 2024
EKU Podcast: Faecal immunochemical testing
Colorectal cancer is the fourth most common type of cancer in the UK, with over 40,000 new cases each year. The positive predictive value of Faecal immunochemical testing (FIT) far exceeds that of symptoms and makes FIT an important tool for triaging patients with symptoms sugges ... Show More
21m 21s
Nov 2022
Talk Evidence - Diabetes data, colonoscopies, and researchers behaving badly
In this month's Talk Evidence, Helen Macdonald, The BMJ's research integrity editor, is joined again by Juan Franco, editor in chief of BMJ EBM, and Joe Ross, US research editor. They're straying beyond the pages of The BMJ, and discussing an NEJM paper about colonoscopy for co ... Show More
46m 15s
Oct 2024
Preventing Colon Cancer
What can lifestyle, diet, and 100 trillion micro-organisms do for you? This episode features audio from: The Best Dietary Changes for Colon Cancer Prevention Solving a Colon Cancer Mystery Stool pH and Colon Cancer Visit the video pages for all sources and doctor’s notes related ... Show More
20m 23s
Dec 2022
Cost-effectiveness of Laparoscopic vs Open Gastrectomy
Interview with Arjen van der Veen, MD, PhD, and Richard van Hillegersberg, MD, PhD, authors of Cost-effectiveness of Laparoscopic vs Open Gastrectomy for Gastric Cancer: An Economic Evaluation Alongside a Randomized Clinical Trial. Hosted by Amalia Cochran, MD. Related Content: C ... Show More
19m 17s
Apr 2024
How ctDNA Is Advancing Care for Patients With GI Cancers
<p><span style= "font-size: 12pt; font-family: arial, helvetica, sans-serif;">Drs. Shaalan Beg and Aparna Parikh discuss the role of ctDNA as a powerful prognostic biomarker for GI cancers, along with its impact on risk stratification and the detection of recurrence. They highlig ... Show More
17m 21s